This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Our people: Clinical Innovation Adoptionrss feed

Oxford AHSN Directors and Board members are listed first. Scroll down or click through to the next pages for other members of the Oxford AHSN team. Alternatively, you can refine your search by using the specialties listed below.

Tracey Marriott

Tracey joined the Oxford AHSN in 2013​. She heads Oxford AHSN’s work to identify and implement evidence-based clinical innovation​. She is a transformational change professional with extensive experience (including in the NHS) delivering complex programmes at a regional, national and international level. Tracey leads partnerships across Europe linking with academic and health partners through the European Institute of Innovation […]

Neil Dardis

Neil is Chief Executive of Frimley Health NHS Foundation Trust, taking up the post in March 2018. He was previously Chief Executive of Buckinghamshire Healthcare NHS Trust, a position he held from April 2015. He has an in-depth understanding of acute and teaching hospitals, community and specialist services based on over 20 years’ experience in […]

Andrew Leary

Andrew has an extensive healthcare background with unique experience across clinical, applied technology and innovation roles. He has worked in diverse capacities from direct patient care as a doctor to evaluating health technologies, multi-centre collaboration, delivering complex change and advising senior management. Andrew is also an NHS England Clinical Entrepreneur.

Matthew Epton

Matthew has over ten years’ experience working in the NHS in primary care, holding operational management, strategic management and commissioning roles.  He also has worked in adult social care business support and performance management. Matthew has an academic research background with a D.Phil. from the University of Oxford Medical Sciences Division.

Matt Williams

Matt leads the Oxford AHSN Sleepio project. He has over 20 years’ experience working within the mental health, education and voluntary sectors. Matt was previously the Oxford AHSN Early Intervention in Psychosis Clinical Network Manager. He also facilitates the Thames Valley Suicide Prevention and Intervention Network (SPIN), a multi-agency network promoting the message that preventing […]

Alison Gowdy

Alison has over 15 years’ experience in the NHS working in senior acute operational roles. She has extensive experience liaising with clinical teams and commissioners, working across organisations to improve patient pathways and in delivering change management programmes.

Sarah Brown

Sarah is part of the NIHR Applied Research Collaboration (ARC) team for Oxford and Thames Valley, which she joined at the beginning of April 2020. She works across the University of Oxford and the Oxford AHSN, working with researchers and clinicians to help improve outcomes for patients and the public by supporting the implementation of […]

Seema Gadhia

Seema is the Pharmacy Lead for Clinical Innovation Adoption. Seema has substantial experience of working in community pharmacy; hospital pharmacy; Mental Health Trusts; Primary Care Trusts and Clinical Commissioning Groups. She has also worked as a clinical advisor for Pharmacy Management. Her particular area of expertise is service improvement and has strategically led and delivered […]

Helen Norman

Helen previously worked as an analyst at Oxford University Hospitals, specialising in theatres, cancer and hospital episode statistics. She gained extensive experience in relational databases and acquiring skills in business intelligence packages. Helen’s current role is similar but project based, assisting others by providing meaningful insights through data analysis, interrogating datasets, producing metrics and charting […]

James Rose

James has been working in the life science sector for ten years, holding roles in R&D and market access, discovery and development. He has a PhD in Pharmacy from the University of Nottingham in which he investigated barriers to adoption and reimbursement of biologic therapies. James has been leading on several projects to support the […]